Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)

China flag China · Delayed Price · Currency is CNY
20.54
+0.35 (1.73%)
At close: Mar 10, 2026
44.24%
Market Cap 8.15B
Revenue (ttm) 1.77B
Net Income (ttm) 14.22M
Shares Out 396.81M
EPS (ttm) 0.04
PE Ratio 573.06
Forward PE n/a
Dividend 0.03 (0.15%)
Ex-Dividend Date Jun 25, 2025
Volume 5,910,731
Average Volume 8,117,469
Open 20.30
Previous Close 20.19
Day's Range 20.30 - 20.96
52-Week Range 11.63 - 28.79
Beta 0.84
RSI 41.69
Earnings Date Apr 29, 2026

About SHE:301246

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials... [Read more]

Sector Healthcare
Founded 2002
Employees 2,169
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301246
Full Company Profile

Financial Performance

In 2024, SHE:301246's revenue was 1.77 billion, a decrease of -13.83% compared to the previous year's 2.05 billion. Earnings were 51.47 million, a decrease of -40.96%.

Financial Statements

News

There is no news available yet.